Obermatt
See Similar Stocks →

Alpha Teknova

NMQ:TKNO · US02080L1026
Life Sciences Tools & ServicesSmall

360

32
Profit price81
Owner Earnings Yield1
Dividend Yield1
Price/Sales36
EV / Gross Profit16
Price/Book29
Return on Capital32
Cash Return on Capital38
Return on Equity36
EBIT Margin24
Gross Profitability42
Accruals71
Owner Earnings Margin28
Sales growth63
Profit growth49
Reinvestment54
Price momentum19
Debt load50
Refinancing49
Debt Payback1
Liquidity22
Analyst ratings58
Opinion Changes50
Price Target Upside88
Market mood17
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Alpha Teknova doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
TypePublic Company
ExchangeNASDAQGM
Founded2000
Employees111
Websiteteknova.com
ISINUS02080L1026
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
GeneticsStem Cell TherapyHealth DiagnosticsVaccinesBiotechnologyChemicalMedical

Description

Alpha Teknova, Inc. (Teknova) operates as a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. The company serves more than 3,000 customers spanning the contin…

Analysis

Middle-of-the-road

Alpha Teknova, Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is stretched. The company scores 4/20 on our value-creation score: not creating value. Analysts lean positive.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
4
2023202420252026

All-time high

82

Jan 2025

All-time low

4

Jun 2026

Average rank

36

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
36
15
62
45
Price/Earnings
84
73
73
44
Price/Book
29
31
73
67
Dividend Yield
1
1
1
1
Value (overall)
20
18
65
65

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Alpha Teknova with its peers
Quidel
NSQ:QDEL
9
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Harvard Bioscience
NAQ:HBIO
21
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Repligen
NSQ:RGEN
66
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
Bio-Techne
NSQ:TECH
74
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
BioLife Slutn
NAQ:BLFS
50
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Charles River Laboratories
NYQ:CRL
17
CountryUSA
IndustryLife Sciences Tools & Services
SizeX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →